Genomic Sequencing Cos. Face FTC Scrutiny On $1B Deal
DNA-sequencing company Illumina Inc.'s $1.2 billion bid to purchase genetic sequencing systems firm Pacific Biosciences of California Inc. is drawing extra scrutiny from the Federal Trade Commission....To view the full article, register now.
Already a subscriber? Click here to view full article